Info@ThinkPinkRocks.com

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

Visit link:
Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Share

Leave a Reply